Regenerative Biotechnology
Gencell® CTM Metabolic
Preconditioned mesenchymal stem cells for metabolic and lipid support.
Injectable solution of mesenchymal stem cells pretreated with evolocumab, designed to modulate inflammation, repair endothelium, and support lipid metabolism regulation in dyslipidemia.
Composition
Mesenchymal stem cells pretreated with evolocumab.
Pharmaceutical form
Injectable solution.
Presentation
Single-dose vial, 4 ml.
Therapeutic properties
Promote tissue repair through immunomodulation, inflammation reduction, apoptosis inhibition, cellular stimulation, and improvement of lipid homeostasis through PCSK9 inhibition.
- Modulation of systemic inflammation.
- Regulation of LDL cholesterol.
- Protection of vascular endothelium.
- Inhibition of cellular apoptosis.
- Stimulation of tissue regeneration.
- Improvement of lipid profile.
- Reduction of endothelial damage.
- Support for metabolic homeostasis.
Mechanism of action & Clinical data
Migrate to damaged tissue, modulate inflammation, inhibit apoptosis and, through PCSK9 inhibition, increase LDL uptake and support endothelial regeneration.